Validity of SW982 synovial cell line for studying the drugs against rheumatoid arthritis in fluvastatin-induced apoptosis signaling model

Indian Journal of Medical Research

Volumn 139, Issue , 2014, Pages 117-124

  Chang, Jae Ho ^a   Lee, Kyu Jae ^b   Kim, Soo Ki ^a,b   Yoo, Dae Hyun ^c   Kang, Tae Young ^b  

^a Yonsei University Wonju   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

^c Hanyang University Medical Center   (South Korea)

Author keywords

Apoptosis; Fluvastatin; PI3K Akt; Rac1; RhoA; SW982 human synovial cells

Indexed keywords

FLUINDOSTATIN; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROPIDIUM IODIDE; PROTEIN KINASE B; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; GERANYLGERANYL PYROPHOSPHATE; INDOLE DERIVATIVE; ISOPRENOID PHOSPHATE; MONOUNSATURATED FATTY ACID; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; FLOW CYTOMETRY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; PATHOLOGY; SIGNAL TRANSDUCTION; SYNOVIAL FLUID;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL LINE; CELL SURVIVAL; FATTY ACIDS, MONOUNSATURATED; HUMANS; INDOLES; MEMBRANE POTENTIAL, MITOCHONDRIAL; POLYISOPRENYL PHOSPHATES; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84896805747     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Vieira-Sousa E, Gerlag DM, Tak PP. Synovial tissue response to treatment in rheumatoid arthritis. Open Rheumatol J 2011; 5: 115-22.
2. Komatsu N, Takayanagi H. Bone and cartilage destruction in RA and its intervention. Bone and cartilage destruction in rheumatoid arthritis. Clin Calcium 2012; 22: 179-85.
3. Hitchon CA, El-Gabalawy HS. The synovium in rheumatoid arthritis. Open Rheumatol J 2011; 5: 107-14.
4. Niedermeier M, Pap T, Korb A. Therapeutic opportunities in fibroblasts in inflammatory arthritis. Best Pract Res Clin Rheumatol 2010; 24: 527-40.
5. Miller MC, Manning HB, Jain A, Troeberg L, Dudhia J, Essex D, et al. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum 2009; 60: 686-97.
6. Tong XM, Wang JC, Shen Y, Xie JJ, Zhang JY, Jin J. Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts. Inflamm Res 2011; 60: 823-9.
7. Scian R, Barrionuevo P, Giambartolomei GH, De Simone EA, Vanzulli SI, Fossati CA, et al. Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases. Infect Immun 2011; 79: 3619-32.
8. Imaizumi T, Matsumiya T, Yoshida H, Naraoka T, Uesato R, Ishibashi Y, et al. Tumor-necrosis factor-alpha induces retinoic acid-inducible gene-I in rheumatoid fibroblast-like synoviocytes. Immunol Lett 2009; 122: 89-93.
9. Caporali R, Pallavicini FB, Filippini M, Gorla R, Marchesoni A, Favalli EG, et al. Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal. Autoimmun Rev 2009; 8: 274-80.
10. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2002; 2: 364-71.
11. Yokota K, Miyoshi F, Miyazaki T, Sato K, Yoshida Y, Asanuma Y, et al. High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 2008; 35: 193-200.
12. Nanke Y, Kawamoto M, Yago T, Chiba J, Yamanaka H, Kotake S. Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Mod Rheumatol 2009; 19: 379-83.
13. Ogata Y, Takahashi M, Takeuchi K, Ueno S, Mano H, Ookawara S, et al. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. J Cardiovasc Pharmacol 2002; 40: 907-15.
14. Itagaki M, Takaguri A, Kano S, Kaneta S, Ichihara K, Satoh K. Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats. J Pharmacol Sci 2009; 109: 94-101.
15. Matzno S, Yasuda S, Juman S, Yamamoto Y, Nagareya-Ishida N, Tazuya-Murayama K, et al. Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein. J Pharm Pharmacol 2005; 57: 1475-84.
16. Connor AM, Berger S, Narendran A, Keystone EC. Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts. Arthritis Res Ther 2006; 8: R94.
17. Zhao C, Fernandes MJ, Turgeon M, Tancrede S, Di Battista J, Poubelle PE, et al. Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha. J Lipid Res 2008; 49: 2323-37.
18. Fischetti F, Carretta R, Borotto G, Durigutto P, Bulla R, Meroni PL, et al. Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. Clin Exp Immunol 2004; 135: 186-93.
19. Haruna Y, Morita Y, Yada T, Satoh M, Fox DA, Kashihara N. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis. Arthritis Rheum 2007; 56: 1827-35.
20. Nagashima T, Okazaki H, Yudoh K, Matsuno H, Minota S. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. Arthritis Rheum 2006; 54: 579-86.
21. Tsuji F, Oki K, Senda T, Horiuchi M, Mita S. Effects of mitogenactivated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells. Immunol Lett 1999; 68: 275-9.
22. Kim KO, Park SY, Han CW, Chung HK, Yoo DH, Han JS. Effect of sildenafil citrate on interleukin-1beta-induced nitric oxide synthesis and iNOS expression in SW982 cells. Exp Mol Med 2008; 40: 286-93.
23. Song JS, Kim CH, Heo JY, Cho YS. Rosiglitazone reduces a wide range of proinflammatory profiles in synovial fibroblast SW982 under spheroid culture. Immunol Lett 2010; 131: 81-8.
24. Liagre B, Leger DY, Vergne-Salle P, Beneytout JL. MAP kinase subtypes and Akt regulate diosgenin-induced apoptosis of rheumatoid synovial cells in association with COX-2 expression and prostanoid production. Int J Mol Med 2007; 19: 113-22.
25. Del Re DP, Miyamoto S, Brown JH. Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection. J Biol Chem 2008; 283: 35622-9.
26. Lee YJ, Song JH, Oh MH, Lee YJ, Kim YB, Im JH, et al. ERK1/2 activation in quercetin-treated BEAS-2B cell plays a role in Nrf2-driven HO-1 expression. Mol Cell Toxicol 2011; 7: 347-55.
27. Kang EH, Kim DJ, Lee EY, Lee YJ, Lee EB, Song YW. Downregulation of heat shock protein 70 protects rheumatoid arthritis fibroblast-like synoviocytes from nitric oxide-induced apoptosis. Arthritis Res Ther 2009; 11: R130.
28. Woo JT, Nakagawa H, Krecic AM, Nagai K, Hamilton AD, Sebti SM, et al. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha). Biochem Pharmacol 2005; 69: 87-95.
29. Maeda S, Sakamoto K, Matsuoka I, Iwamoto T, Kimura J. Lysophosphatidylcholine increases Na+/Ca2+ exchanger expression via RhoB-geranylgeranylation in H9c2 cells. J Pharmacol Sci 2009; 109: 565-72.
30. Tang D, Park HJ, Georgescu SP, Sebti SM, Hamilton AD, Galper JB. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. Life Sci 2006; 79: 1484-92.